BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10817663)

  • 1. Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase.
    Worek F; Eyer P; Kiderlen D; Thiermann H; Szinicz L
    Arch Toxicol; 2000 Mar; 74(1):21-6. PubMed ID: 10817663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds.
    Worek F; Kirchner T; Bäcker M; Szinicz L
    Arch Toxicol; 1996; 70(8):497-503. PubMed ID: 8783813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
    Jun D; Kuca K; Picha J; Koleckar V; Marek J
    Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics.
    Worek F; Diepold C; Eyer P
    Arch Toxicol; 1999 Feb; 73(1):7-14. PubMed ID: 10207609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
    Kuca K; Jun D
    J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro reactivation of sarin-inhibited brain acetylcholinesterase from different species by various oximes.
    Kuca K; Cabal J; Kassa J
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):227-32. PubMed ID: 16119192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different oximes on rat and human cholinesterases inhibited by methamidophos: a comparative in vitro and in silico study.
    Lugokenski TH; Gubert P; Bueno DC; Nogara PA; de Aquino Saraiva R; Barcelos RP; Carratu VS; Bresolin L; de Vargas Barbosa NB; Pereira ME; da Rocha JB; Soares FA
    Basic Clin Pharmacol Toxicol; 2012 Dec; 111(6):362-70. PubMed ID: 22703537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro reactivation of acetylcholinesterase using the oxime K027.
    Kuca K; Kassa J
    Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
    Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
    Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of bis-pyridinium oximes bearing methoxy alkane linker as reactivators of sarin inhibited human acetylcholinesterase.
    Acharya J; Dubey DK; Raza SK
    Toxicol In Vitro; 2010 Sep; 24(6):1797-802. PubMed ID: 20600799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
    Worek F; Aurbek N; Thiermann H
    J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reactivation of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing methoxy ether linkages.
    Acharya J; Gupta AK; Mazumder A; Dubey DK
    Toxicol In Vitro; 2008 Mar; 22(2):525-30. PubMed ID: 18061396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
    Maxwell DM; Koplovitz I; Worek F; Sweeney RE
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.